BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/24/2020 12:21:39 PM | Browse: 780 | Download: 1837
 |
Received |
|
2020-03-14 02:59 |
|
Peer-Review Started |
|
2020-03-14 03:05 |
|
First Decision by Editorial Office Director |
|
2020-04-22 19:10 |
|
Return for Revision |
|
2020-04-22 19:10 |
|
Revised |
|
2020-04-26 00:44 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-07-01 10:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-07-04 03:55 |
|
Articles in Press |
|
2020-07-04 03:55 |
|
Edit the Manuscript by Language Editor |
|
2020-07-12 22:02 |
|
Typeset the Manuscript |
|
2020-07-22 02:03 |
|
Publish the Manuscript Online |
|
2020-07-24 12:21 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xing-Tong Wang, Wei Guo, Mo Sun, Wei Han, Zhong-Hua Du, Xiu-Xiu Wang, Bei-Bei Du and Ou Bai |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Grant from Department of Finance of Jilin Province |
2018SCZWSZX-031 |
|
| Corresponding Author |
Ou Bai, MD, PhD, Chief Doctor, Professor, Department of Hematology, The First Hospital of Jilin University, Jilin Provincial Hematology Research Institute, National key Discipline, No. 71, Xinmin Street, Changchun 130021, Jilin Province, China. baiou@jlu.edu.cn |
| Key Words |
Hepatosplenic T-cell lymphoma; Gamma-delta T-cell lymphoma; Chidamide; Novel agent; Case report; |
| Core Tip |
Hepatosplenic T-cell lymphoma is a rare disease that progresses quickly and has poor prognosis. Patients usually show short-term rapid disease progress with a traditional inductive regimen, leaving no opportunity for hematopoietic stem cell transplantation. We employed the histone deacetylase inhibitors Chidamide combined with a dose-adjusted ifosfamide, carboplatin, etoposide regimen and Chidamide single-drug oral maintenance therapy for the management of this patient and turn out a satisfactory outcome. |
| Publish Date |
2020-07-24 12:21 |
| Citation |
Wang XT, Guo W, Sun M, Han W, Du ZH, Wang XX, Du BB, Bai O. Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report. World J Clin Cases 2020; 8(14): 3122-3129 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i14/3122.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i14.3122 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
